Clinical Pharmacokinetics

Acknowledgement to Referees

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

E. J. Smolders, C. T. M. M. de Kanter, R. J. de Knegt, M. van der Valk, J. P. H. Drenth, D. M. Burger

A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration

Parag Kumar, Emily Thudium, Kevin Laliberte, David Zaccardelli, Andrew Nelsen

Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations

Antonio Torres, Johan Willem Mouton, Federico Pea

Population Genetic-Based Pharmacokinetic Modeling of Methadone and its Relationship with the QTc Interval in Opioid-Dependent Patients

Chantal Csajka, Séverine Crettol, Monia Guidi, Chin B. Eap

Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole

Nicolas Hohmann, Franziska Kocheise, Alexandra Carls, Jürgen Burhenne, Johanna Weiss, Walter E. Haefeli, Gerd Mikus

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

Mohamed-Eslam F. Mohamed, Heidi S. Camp, Ping Jiang, Robert J. Padley, Armen Asatryan, Ahmed A. Othman

Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations

Phyllis Chan, Diane R. Mould, Malaz Abu Tarif, Laurie Reynolds, Frank LaCreta, Richard Bertz, Marc Bifano

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

Jan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, Markus Krauss, Stefan Willmann, Thomas Eissing, Ulrich Jaehde